The Effectiveness of Zoledronic Acid and Ibandronic Acid in Delaying Skeletal-Related Events in Multiple Myeloma in Indonesia

Zoledronic acid and ibandronic acid are listed in the Indonesian national formulary to prevent skeletal-related events (SRE) in patients diagnosed with bone metastasis in multiple myeloma (MM), with limited evidence to compare their effectiveness. This study aimed to investigate the effectiveness an...

Full description

Bibliographic Details
Main Authors: Nutrisia Aquariushinta Sayuti, Tri Murti Andayani, Dwi Endarti, Kartika Widayati
Format: Article
Language:Indonesian
Published: Universitas Gadjah Mada 2020-09-01
Series:Jurnal Manajemen dan Pelayanan Farmasi
Subjects:
Online Access:https://jurnal.ugm.ac.id/jmpf/article/view/55943
_version_ 1811273458134286336
author Nutrisia Aquariushinta Sayuti
Tri Murti Andayani
Dwi Endarti
Kartika Widayati
author_facet Nutrisia Aquariushinta Sayuti
Tri Murti Andayani
Dwi Endarti
Kartika Widayati
author_sort Nutrisia Aquariushinta Sayuti
collection DOAJ
description Zoledronic acid and ibandronic acid are listed in the Indonesian national formulary to prevent skeletal-related events (SRE) in patients diagnosed with bone metastasis in multiple myeloma (MM), with limited evidence to compare their effectiveness. This study aimed to investigate the effectiveness and safety of zoledronic acid and ibandronic acid in delaying SRE. The method was the retrospective, with data obtained from the multicenter study for MM patients with bone metastasis (aged over 18 years), based on medical records between January 2016 and December 2018. Patients were assigned to zoledronic acid and ibandronic acid groups. The clinical outcome was the next SRE which consists of vertebral/bone fracture, spinal cord compression leading to the need for surgery or radiation, and adverse event (AE) due to 2 years of drugs usage. Result of this research was made up of a total of seventy (70) patients with  40  in the zoledronic acid group, and 30 in ibandronic acid. At median treatment duration of 8 months (range: 2 – 24 month), SRE incident in zoledronic acid and ibandronic acid were 20.0 % and 23.3 % respectively. Furthermore, their mean SRE free survival times were 21 months [95% confidence interval (CI) 19 - 23 months], and 19 months [95% CI, 16 – 22 months], respectively. Also, their time intervals were not significantly different (p>0.05). The osteonecrosis of the jaw (ONJ) was AE which occurred more in zoledronic acid than ibandronic acid. The conclusion was zoledronic acid tends to delay SRE time compared to ibandronic acid, although more ONJ occur.
first_indexed 2024-04-12T22:59:30Z
format Article
id doaj.art-cccafa597e774d81a0ceef5cdc25064e
institution Directory Open Access Journal
issn 2088-8139
2443-2946
language Indonesian
last_indexed 2024-04-12T22:59:30Z
publishDate 2020-09-01
publisher Universitas Gadjah Mada
record_format Article
series Jurnal Manajemen dan Pelayanan Farmasi
spelling doaj.art-cccafa597e774d81a0ceef5cdc25064e2022-12-22T03:13:06ZindUniversitas Gadjah MadaJurnal Manajemen dan Pelayanan Farmasi2088-81392443-29462020-09-0110319520310.22146/jmpf.5594328427The Effectiveness of Zoledronic Acid and Ibandronic Acid in Delaying Skeletal-Related Events in Multiple Myeloma in IndonesiaNutrisia Aquariushinta Sayuti0Tri Murti Andayani1Dwi Endarti2Kartika Widayati31) Doctoral Program, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 3) Indonesian Herbal Medicine Department, Health Polytechnic of Surakarta, Ministry of Health IndonesiaDoctoral Program, Faculty of Pharmacy, Universitas Gadjah Mada, YogyakartaDoctoral Program, Faculty of Pharmacy, Universitas Gadjah Mada, YogyakartaDivision of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada/Dr. Sardjito Hospital, YogyakartaZoledronic acid and ibandronic acid are listed in the Indonesian national formulary to prevent skeletal-related events (SRE) in patients diagnosed with bone metastasis in multiple myeloma (MM), with limited evidence to compare their effectiveness. This study aimed to investigate the effectiveness and safety of zoledronic acid and ibandronic acid in delaying SRE. The method was the retrospective, with data obtained from the multicenter study for MM patients with bone metastasis (aged over 18 years), based on medical records between January 2016 and December 2018. Patients were assigned to zoledronic acid and ibandronic acid groups. The clinical outcome was the next SRE which consists of vertebral/bone fracture, spinal cord compression leading to the need for surgery or radiation, and adverse event (AE) due to 2 years of drugs usage. Result of this research was made up of a total of seventy (70) patients with  40  in the zoledronic acid group, and 30 in ibandronic acid. At median treatment duration of 8 months (range: 2 – 24 month), SRE incident in zoledronic acid and ibandronic acid were 20.0 % and 23.3 % respectively. Furthermore, their mean SRE free survival times were 21 months [95% confidence interval (CI) 19 - 23 months], and 19 months [95% CI, 16 – 22 months], respectively. Also, their time intervals were not significantly different (p>0.05). The osteonecrosis of the jaw (ONJ) was AE which occurred more in zoledronic acid than ibandronic acid. The conclusion was zoledronic acid tends to delay SRE time compared to ibandronic acid, although more ONJ occur.https://jurnal.ugm.ac.id/jmpf/article/view/55943multiple myelomazoledronic acidibandronic acidsresafety
spellingShingle Nutrisia Aquariushinta Sayuti
Tri Murti Andayani
Dwi Endarti
Kartika Widayati
The Effectiveness of Zoledronic Acid and Ibandronic Acid in Delaying Skeletal-Related Events in Multiple Myeloma in Indonesia
Jurnal Manajemen dan Pelayanan Farmasi
multiple myeloma
zoledronic acid
ibandronic acid
sre
safety
title The Effectiveness of Zoledronic Acid and Ibandronic Acid in Delaying Skeletal-Related Events in Multiple Myeloma in Indonesia
title_full The Effectiveness of Zoledronic Acid and Ibandronic Acid in Delaying Skeletal-Related Events in Multiple Myeloma in Indonesia
title_fullStr The Effectiveness of Zoledronic Acid and Ibandronic Acid in Delaying Skeletal-Related Events in Multiple Myeloma in Indonesia
title_full_unstemmed The Effectiveness of Zoledronic Acid and Ibandronic Acid in Delaying Skeletal-Related Events in Multiple Myeloma in Indonesia
title_short The Effectiveness of Zoledronic Acid and Ibandronic Acid in Delaying Skeletal-Related Events in Multiple Myeloma in Indonesia
title_sort effectiveness of zoledronic acid and ibandronic acid in delaying skeletal related events in multiple myeloma in indonesia
topic multiple myeloma
zoledronic acid
ibandronic acid
sre
safety
url https://jurnal.ugm.ac.id/jmpf/article/view/55943
work_keys_str_mv AT nutrisiaaquariushintasayuti theeffectivenessofzoledronicacidandibandronicacidindelayingskeletalrelatedeventsinmultiplemyelomainindonesia
AT trimurtiandayani theeffectivenessofzoledronicacidandibandronicacidindelayingskeletalrelatedeventsinmultiplemyelomainindonesia
AT dwiendarti theeffectivenessofzoledronicacidandibandronicacidindelayingskeletalrelatedeventsinmultiplemyelomainindonesia
AT kartikawidayati theeffectivenessofzoledronicacidandibandronicacidindelayingskeletalrelatedeventsinmultiplemyelomainindonesia
AT nutrisiaaquariushintasayuti effectivenessofzoledronicacidandibandronicacidindelayingskeletalrelatedeventsinmultiplemyelomainindonesia
AT trimurtiandayani effectivenessofzoledronicacidandibandronicacidindelayingskeletalrelatedeventsinmultiplemyelomainindonesia
AT dwiendarti effectivenessofzoledronicacidandibandronicacidindelayingskeletalrelatedeventsinmultiplemyelomainindonesia
AT kartikawidayati effectivenessofzoledronicacidandibandronicacidindelayingskeletalrelatedeventsinmultiplemyelomainindonesia